Targeted exonic sequencing identifies novel variants in a cerebral small vessel disease cohort
- PMID: 39743006
- DOI: 10.1016/j.cca.2024.120120
Targeted exonic sequencing identifies novel variants in a cerebral small vessel disease cohort
Abstract
Background and aims: Cerebral small vessel diseases (CSVDs) are a set of conditions that affect the small blood vessels in the brain and can cause severe neurological pathologies such as stroke and vascular dementia. The most common monogenic CSVD is cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) which is caused by mutations in NOTCH3. However, only 15-20% of CADASIL cases referred for genetic testing have pathogenic mutations in NOTCH3. We hypothesise that other monogenic causes of CSVD may be causing a CADASIL-like CSVD phenotype.
Methods: To test this, we performed whole exome sequencing for 50 individuals suspected of having CADASIL, but did not exhibit a disease-causing mutation in NOTCH3, and applied targeted analysis of all monogenic forms of CSVD.
Results: This analysis identified three mutations affecting the Collagen type IV genes in three individuals likely to be causative of CSVD.
Conclusions: This suggests that screening for all monogenic forms of CSVD when one monogenic form is clinically suspected may improve diagnosis in clinically suspected monogenic CSVD. However, despite these findings, the majority of NOTCH3 negative CSVD cases did not have candidate mutations in known CSVD genes, suggesting that additional genetic factors contributing to the disease are yet to be identified.
Keywords: CADASIL; Cerebral small vessel disease; Collagen Type IV; Targeted exonic sequencing.
Copyright © 2024. Published by Elsevier B.V.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
CADASIL: A NOTCH3-associated cerebral small vessel disease.J Adv Res. 2024 Dec;66:223-235. doi: 10.1016/j.jare.2024.01.001. Epub 2024 Jan 2. J Adv Res. 2024. PMID: 38176524 Free PMC article. Review.
-
Investigating a Genetic Link Between Alzheimer's Disease and CADASIL-Related Cerebral Small Vessel Disease.Mol Neurobiol. 2022 Dec;59(12):7293-7302. doi: 10.1007/s12035-022-03039-3. Epub 2022 Sep 29. Mol Neurobiol. 2022. PMID: 36175824 Free PMC article.
-
Monogenic cerebral small-vessel diseases: diagnosis and therapy. Consensus recommendations of the European Academy of Neurology.Eur J Neurol. 2020 Jun;27(6):909-927. doi: 10.1111/ene.14183. Epub 2020 Mar 20. Eur J Neurol. 2020. PMID: 32196841
-
Whole-exome sequencing of Finnish patients with vascular cognitive impairment.Eur J Hum Genet. 2021 Apr;29(4):663-671. doi: 10.1038/s41431-020-00775-9. Epub 2020 Dec 2. Eur J Hum Genet. 2021. PMID: 33268848 Free PMC article.
-
Monogenic causes of cerebral small vessel disease and stroke.Handb Clin Neurol. 2024;204:273-287. doi: 10.1016/B978-0-323-99209-1.00018-1. Handb Clin Neurol. 2024. PMID: 39322384 Review.
Cited by
-
Genetic Architecture of Ischemic Stroke: Insights from Genome-Wide Association Studies and Beyond.J Cardiovasc Dev Dis. 2025 Jul 23;12(8):281. doi: 10.3390/jcdd12080281. J Cardiovasc Dev Dis. 2025. PMID: 40863347 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous